HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.

AuthorsGiovanna Liuzzo, Carlo Patrono
JournalEuropean heart journal (Eur Heart J) Vol. 43 Issue 25 Pg. 2354-2355 (07 01 2022) ISSN: 1522-9645 [Electronic] England
PMID35551379 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Warfarin
  • Factor XIa
Topics
  • Administration, Oral
  • Anticoagulants (therapeutic use)
  • Atrial Fibrillation (drug therapy)
  • Factor XIa
  • Hemostasis
  • Humans
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: